Clinical Molecular Genetics Fellowship
Program Training Director: Jacquelyn R. Roberson M.D., FACMG
Laboratory Training Director: Kristin G. Monaghan, Ph.D., FACMG
Program Coordinator: Pamela Johnson
Direct inquires to: Dr. Roberson 1-800-999-4340 (toll free) extension 16-3188
Out of state: 1-800-434-8834
The Department of Medical Genetics offers two positions annually for a twenty-four month American Board of Medical Genetics (ABMG)-accredited Clinical Molecular Genetics Fellowship Program supported by Henry Ford Health System. This is one of the largest and most respected integrated health care delivery systems in the country.
Our trainees utilize the latest technology and learn from highly skilled clinical staff at Henry Ford Hospital, a nationally renowned specialty care, teaching and research institution that is the flagship of Henry Ford Health System. Our hospital serves the metropolitan Detroit population as well as the surrounding suburbs. Trainees benefit from this large and diverse patient population.
Trainees entering this specialty must hold either an M.D. or Ph.D. (or their equivalent); the Ph.D. degree must either be in genetics, molecular biology, or a related field within the biological sciences. Individuals with a M.D. or Ph.D. earned outside of the United States or Canada are recommended to have their degree reviewed by the ABMG Credentials Committee prior to entering into the training program.
The laboratory training experience encompasses all aspects of genetic testing including pre-analytical, analytical and post-analytical phases. The trainee will gain experience with a wide variety of molecular techniques, test indications (including diagnostic, predisposition and carrier testing), and sample types (including prenatal specimens). Training also includes a research project, which may involve the development of a new clinical test. In addition to molecular training, fellows are exposed to other areas of genetics including Cytogenetics, Biochemical Genetics, and Clinical Genetics. Trainees are also required to take two semesters of graduate level genetics courses at a local University during their fellowship.
Our training objectives are to develop proficiencies in all areas of clinical molecular genetics including:
- A broad knowledge of molecular genetics
- The application of molecular techniques to the diagnosis of inherited disease
- The ability to understand, perform, and trouble-shoot a variety of molecular assays
- The ability to appropriately interpret and communicate molecular laboratory results in the capacity of a consultant to health care providers
- The ability to supervise and direct the operation of a clinical molecular genetics laboratory, including all aspects of quality control and quality assurance
One of the greatest strengths of our program is our staff's commitment to excellence. Each staff member works solely in medical genetics, providing our trainees with a team of focused and experienced health care professionals from whom to learn. Our staff includes 6 ABMG certified geneticists: two Pediatric Geneticists (one also board certified in Clinical Biochemical Genetics), an Obstetrical Reproductive Geneticist, an Internal Medicine Geneticist, a Clinical Molecular Geneticist (who is also board certified in PhD Medical Genetics) and a Clinical Cytogeneticist (who is also board certified in Clinical Molecular Genetics). In addition, we have several certified genetic counselors and genetic nurse associates in the Department. Our staff is committed to ensuring that our graduates have an exceptional, well-rounded training experience.
Upon successful completion of the program, a trainee can apply to sit for the ABMG Clinical Molecular Genetics certification examination. Clinical Molecular Genetics is recognized as a primary specialty by the American Board of Medical Specialties (ABMS). ABMG certified Clinical Molecular Geneticists have the skills and knowledge to function as technical supervisors of clinical laboratories as well as clinical consultants regarding laboratory diagnoses of a broad range of inherited disorders, and may in many jurisdictions be deemed qualified to direct specialty clinical molecular laboratories.